Boston Scientific Corporation

BSX

US1011371077

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 21:00:02 06/09/2024 BST			5-day change	1st Jan Change
81.60 ^USD	+0.28%		-0.23%	+41.15%

09-04	Raymond James Adjusts Price Target on Boston Scientific to $94 From $91, Maintains Strong Buy Rating	MT
09-04	Transcript : Boston Scientific Corporation Presents at Wells Fargo 2024 Healthcare Conference, Sep-04-2024 08:00 AM

This article is reserved for members

To unlock the article, REGISTER!

100% Free Registration

Already a customer? Log In

Latest news about Boston Scientific Corporation

Raymond James Adjusts Price Target on Boston Scientific to $94 From $91, Maintains Strong Buy Rating	09-04	MT
Transcript : Boston Scientific Corporation Presents at Wells Fargo 2024 Healthcare Conference, Sep-04-2024 08:00 AM	09-04
Boston Scientific Insider Sold Shares Worth $570,511, According to a Recent SEC Filing	09-03	MT
Boston Scientific Insider Sold Shares Worth $1,130,560, According to a Recent SEC Filing	08-29	MT
Boston Scientific Secures CE Mark for Acurate Prime Aortic Valve System	08-27	MT
Boston Scientific Insider Sold Shares Worth $1,110,515, According to a Recent SEC Filing	08-26	MT
Citigroup Adjusts Price Target on Boston Scientific to $92 From $90, Maintains Buy	08-22	MT
Barclays Adjusts Price Target on Boston Scientific to $86 From $78, Maintains Overweight	08-22	MT
Boston Scientific Insider Sold Shares Worth $517,580, According to a Recent SEC Filing	08-01	MT
Boston Scientific Insider Sold Shares Worth $517,580, According to a Recent SEC Filing	08-01	MT
Argus Adjusts Price Target on Boston Scientific to $90 From $95	07-31	MT
Boston Scientific Corporation Elects David Habiger to Board of Directors	07-30	CI
Daiwa Securities Adjusts Price Target on Boston Scientific to $83 From $81, Maintains Buy Rating	07-30	MT
UBS Adjusts Boston Scientific Price Target to $94 From $90, Maintains Buy Rating	07-26	MT
Boston Scientific's 'Solid' New 2024 Guidance Has Room for Upside, RBC Says	07-25	MT
Bernstein Adjusts Boston Scientific's PT to $92 From $86, Maintains Outperform Rating	07-25	MT
Nephron Research Adjusts Price Target on Boston Scientific to $95 From $85	07-25	MT
Wolfe Research Adjusts Price Target on Boston Scientific to $84 From $81, Maintains Outperform Rating	07-25	MT
Wells Fargo Adjusts Price Target on Boston Scientific to $87 From $82, Maintains Overweight Rating	07-25	MT
Canaccord Genuity Adjusts Price Target on Boston Scientific to $88 From $83, Maintains Buy Rating	07-25	MT
Baird Adjusts Price Target on Boston Scientific to $91 From $90, Maintains Outperform Rating	07-25	MT
Needham Adjusts Price Target on Boston Scientific to $86 From $82, Maintains Buy Rating	07-25	MT
Goldman Sachs Adjusts Price Target on Boston Scientific to $91 From $90, Maintains Buy Rating	07-25	MT
JPMorgan Adjusts Price Target on Boston Scientific to $85 From $82, Maintains Overweight Rating	07-25	MT
Deutsche Bank Adjusts Price Target on Boston Scientific to $78 From $73, Maintains Hold Rating	07-25	MT

Chart Boston Scientific Corporation

Duration

Period

More charts

Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (60.6%): products used in cardiology surgeries (27.4% of net sales), cardiac rhythm management (25.2%), peripheral surgeries (23.9%), electrophysiology tests (9.1%) and other (14.4%); - endodontic surgery (37.4%): equipment used in endoscopy (45.8% of net sales), urology (36.2%) and other (18%) ; - neuromodulation (2%). The United States account for 59.2% of net sales.

Employees

48,000

Sector

Advanced Medical Equipment & Technology

Calendar

22/10/2024 - Q3 2024 Earnings Release (Projected)

Related indices

S&P 500

More about the company